WHO ICTRP trial
Hypertonic saline in cutaneous leishmaniasis
SLCTR/2013/024 · Sri Lanka Clinical Trials Registry (SLCTR) · Not Recruiting
Key facts
| Trial ID | SLCTR/2013/024 |
|---|---|
| Public title | Hypertonic saline in cutaneous leishmaniasis |
| Scientific title | Randomized, double blind, controlled, comparative clinical trial on efficacy and safety of intralesional 10% and 15% hypertonic saline vs sodium stiboglucate in cutaneous leishmaniasis |
| Primary sponsor | Teaching Hospital Anuradhapura |
| Registry | Sri Lanka Clinical Trials Registry (SLCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | Sri Lanka |
| Conditions | Cutaneous leishmaniasis |
| Interventions | Consenting patients will be randomized into three arms in 2: 2: 1 ratio considering the unwanted effects that may arise with 15% hypertonic saline. The first arm (A) will receive intralesional sodium stibogluconate (standard therapy), (B)… |
| Registration date | Aug 7, 2013 |
| Target size | 250 (100, 100 and 50 in each arm) |
| Registry page | slctr.lk |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: